Lurker Nancy
Director at COLL; Director at EYPT; Director at AUXILIUM PHARMACEUTICALS INC
- Sold, on record
- $2.9M
- Dollars the filings state
- Form 4 sales
- 7
- Latest May 13, 2026
- Form 144 notices
- 3
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- COLLCOLLEGIUM PHARMACEUTICAL, INCDirector
- EYPTEyePoint Pharmaceuticals, Inc.Director
- AUXILIUM PHARMACEUTICALS INCDirector
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- EYPT75,000 shares
- AUXILIUM PHARMACEUTICALS INC32,430 shares
- COLL4,500 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 144 notice EYPTNoticeDec 4, 2023 2023
Filed to sell 20,000 shares ($415k)
Lurker Nancy, Director
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale EYPTRoutineDec 4, 2023 same day
Sold 20,000 shares at $20.76 ($415k)
Lurker Nancy, Executive Vice Chair
10b5-1 planSold 10.5% of holdings ($4M position)170,559 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice EYPTNoticeJan 23, 2024 +50 days
Filed to sell 5,044 shares ($126k)
Lurker Nancy, Director
10b5-1 planFiling
- 4 Form 144 notice EYPTNoticeJan 24, 2024 +1 day
Filed to sell 29,956 shares ($748k)
Lurker Nancy, Director
10b5-1 planFiling
- 5 Form 4 sale EYPTRoutineJan 24, 2024 same day
Sold 35,000 shares at $24.98 ($874k)
Lurker Nancy, Executive Vice Chair
10b5-1 planSold 20.5% of holdings ($4.3M position)135,441 shares leftFollows a Form 144Filing
- 6 Form 4 sale EYPTRoutineNov 28, 2025 +674 days
Sold 700 shares at $14.95 ($10k)
Lurker Nancy, Director
10b5-1 planSold 0.3% of holdings ($3.2M position)215,847 shares leftFiling
- 7 Form 4 sale EYPTRoutineDec 4, 2025 +6 days
Sold 9,300 shares at $15.11 ($141k)
Lurker Nancy, Director
10b5-1 planSold 4.3% of holdings ($3.3M position)206,547 shares leftFiling
- 8 Form 4 sale COLLNo planMay 13, 2026 +160 days
Sold 4,500 shares at $35.97 ($162k)
Lurker Nancy, Director
No 10b5-1 planSold 20% of holdings ($810k position)18,017 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | May 15, 2026 | COLL | Director | Form 4 sale | 4,500 | $162k | 20.0% | No plan | SEC |
| Dec 4, 2025 | Dec 5, 2025 | EYPT | Director | Form 4 sale | 9,300 | $141k | 4.3% | Routine | SEC |
| Nov 28, 2025 | Dec 1, 2025 | EYPT | Director | Form 4 sale | 700 | $10k | 0.3% | Routine | SEC |
| Jan 24, 2024 | Jan 25, 2024 | EYPT | Executive Vice Chair | Form 4 sale | 35,000 | $874k | 20.5% | Routine | SEC |
| Jan 24, 2024 | Jan 24, 2024 | EYPT | Director | Form 144 notice | 29,956 | $748k | Notice | SEC | |
| Jan 23, 2024 | Jan 23, 2024 | EYPT | Director | Form 144 notice | 5,044 | $126k | Notice | SEC | |
| Dec 4, 2023 | Dec 6, 2023 | EYPT | Executive Vice Chair | Form 4 sale | 20,000 | $415k | 10.5% | Routine | SEC |
| Dec 4, 2023 | Dec 4, 2023 | EYPT | Director | Form 144 notice | 20,000 | $415k | Notice | SEC | |
| Nov 15, 2021 | Nov 17, 2021 | EYPT | President & CEO | Form 4 sale | 10,000 | $202k | 8.8% | Plan not stated | SEC |
| Dec 5, 2014 | Dec 8, 2014 | AUXILIUM PHARMACEUTICALS INC | Director | Form 4 sale | 32,430 | $1.1M | 76.4% | Unusual | SEC |